What is the latest SIGACHI stock price?
The latest stored price for SIGACHI is Rs 26.52 as of 2026-11-03.
gimli
SIGACHI stock AI analysis
SIGACHI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
SIGACHI INDUSTRIES LTD is a small-cap stock in Healthcare. This Gimli page shows the latest available SIGACHI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹26.52
1W return
+1.38%
1M return
-6.42%
3M return
-0.34%
6M return
+31.29%
1Y return
-28.11%
Market cap
₹1,013.37 cr
PE
40.21
PB
1.92
ROE
+4.41%
ROCE
+3.65%
RSI
42.83
Turnover
₹6.20 cr
Why it can matter in screens
- Momentum: SIGACHI is below 50DMA, above 200DMA; RSI is 42.83.
- Returns: 1D +2.55%, 1W +1.38%, 1M -6.42%, 3M -0.34%, 1Y -28.11%.
- Trend levels: 52W high ₹38.77, 52W low ₹20.33, off high -31.60%.
- Liquidity: latest turnover is ₹6.20 cr; volume vs 20D is +1.28%.
- Valuation/profitability: PE 40.21, PB 1.92, ROE +4.41%, ROCE +3.65%.
- Growth: 3Y sales CAGR +16.52%, 3Y profit CAGR n/a.
Quick Answers
Is SIGACHI above its 50DMA and 200DMA?
SIGACHI is below 50DMA, above 200DMA. The latest 50DMA is 29.97 and the latest 200DMA is 24.38.
What are SIGACHI PE, ROE and ROCE?
SIGACHI has PE 40.21, ROE +4.41%, and ROCE +3.65% in Gimli's latest available snapshot.
How has SIGACHI performed recently?
SIGACHI has returned -6.42% over 1 month, -0.34% over 3 months, and -28.11% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 121.27 cr | 17.52 cr | 6.76 cr | 0.18 |
| 2026-03-31 | 121.90 cr | 16.62 cr | 7.71 cr | 0.20 |
| 2025-12-31 | 117.21 cr | 5.45 cr | 0.20 cr | 0.01 |
| 2025-09-30 | 112.97 cr | 10.02 cr | 10.53 cr | 0.28 |
| 2025-06-30 | 128.25 cr | -92.96 cr | -100.35 cr | -2.63 |
| 2025-03-31 | 128.20 cr | 30.75 cr | 13.27 cr | 0.39 |
| 2024-12-31 | 139.42 cr | 35.19 cr | 21.35 cr | 0.65 |
| 2024-09-30 | 124.90 cr | 31.86 cr | 21.78 cr | 0.66 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 477.83 cr | -56.21 cr | -81.76 cr | nan |
| 2025-03-31 | 488.24 cr | 120.51 cr | 69.56 cr | 2.06 |
| 2024-03-31 | 398.96 cr | 85.83 cr | 57.18 cr | 1.81 |
| 2023-03-31 | 302.05 cr | 64.20 cr | 43.54 cr | 1.42 |
| 2022-03-31 | 252.03 cr | 55.17 cr | 38.03 cr | 1.54 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 841.17 cr | 20.90 cr | 162.26 cr | 528.88 cr |
| 2025-03-31 | 846.21 cr | 17.26 cr | 142.31 cr | 613.08 cr |
| 2024-03-31 | 694.16 cr | 17.40 cr | 151.07 cr | 441.03 cr |
| 2023-03-31 | 373.75 cr | 13.75 cr | 68.48 cr | 268.36 cr |
| 2022-03-31 | 286.80 cr | 29.08 cr | 34.90 cr | 227.78 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 4.30 cr | -36.86 cr | n/a |
| 2025-03-31 | 26.93 cr | -16.40 cr | n/a |
| 2024-03-31 | 12.89 cr | -72.30 cr | n/a |
| 2023-03-31 | 29.02 cr | -71.70 cr | n/a |
| 2022-03-31 | 5.85 cr | -18.48 cr | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +36.69% | +1.25% | +0.00% | +0.00% | +62.05% | +20.04% |
| 2026-03-31 | +36.69% | +1.30% | +0.00% | +0.00% | +62.01% | +27.71% |
| 2025-12-31 | +39.70% | +3.33% | +0.00% | +0.00% | +56.97% | +40.32% |
| 2025-09-30 | +40.48% | +3.10% | +0.00% | +0.00% | +56.41% | +39.55% |
| 2025-06-30 | +44.14% | +2.89% | +0.00% | +0.00% | +52.97% | +45.37% |
| 2025-03-31 | +44.14% | +0.08% | +0.00% | +0.00% | +55.78% | +45.37% |
| 2025-02-08 | +44.14% | +0.21% | +0.00% | +0.00% | +55.65% | +20.66% |
| 2024-12-31 | +44.71% | +0.16% | +0.00% | +0.00% | +55.12% | +23.37% |
| 2024-09-30 | +44.71% | +1.58% | +0.00% | +0.00% | +53.71% | +23.37% |
| 2024-08-30 | +44.71% | +1.57% | +0.00% | +0.00% | +53.71% | +23.37% |
| 2024-06-30 | +45.43% | +1.56% | +0.00% | +0.00% | +53.01% | +21.70% |
| 2024-03-31 | +45.43% | +2.06% | +0.00% | +0.00% | +52.51% | +21.70% |
| 2024-03-06 | +45.43% | +1.58% | +0.00% | +0.00% | +52.99% | +21.70% |
| 2023-12-31 | +46.08% | +1.76% | +0.00% | +0.00% | +52.17% | n/a |
| 2023-10-09 | +46.08% | +2.46% | +0.00% | +0.00% | +51.46% | +21.70% |
| 2023-09-30 | +48.49% | +0.95% | +0.00% | +0.00% | +50.56% | n/a |
| 2023-06-30 | +48.49% | +0.05% | +0.00% | +0.00% | +51.46% | n/a |
| 2023-03-31 | +48.49% | +0.09% | +0.00% | +0.00% | +51.43% | +0.00% |
| 2022-12-31 | +48.49% | +0.05% | +0.00% | +0.00% | +51.46% | +0.00% |
| 2022-09-30 | +48.48% | +0.08% | +0.01% | +0.00% | +51.43% | +0.00% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 424,658.30 cr | 35.053345 | +15.50% | +3.72% |
| DIVISLAB | DIVI S LABORATORIES LTD | 267,167.60 cr | 91.684145 | +18.37% | +47.91% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 157,377.11 cr | 74.094685 | +16.87% | +28.16% |
| LAURUSLABS | LAURUS LABS LIMITED | 125,408.69 cr | 114.827348 | +21.77% | +138.16% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 124,833.39 cr | 27.818646 | +16.04% | +26.46% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 121,354.29 cr | 57.614911 | +22.62% | +7.87% |
| DRREDDY | DR. REDDY S LABORATORIES | 113,923.95 cr | 40.698752 | +7.80% | +14.41% |
| CIPLA | CIPLA LTD | 112,841.65 cr | 38.950805 | +8.80% | -7.58% |
Try these prompts
- Analyze SIGACHI INDUSTRIES with valuation, momentum and industry peers
- Compare SIGACHI with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare SIGACHI with other Healthcare stocks
Data snapshot: 2026-11-03. Not investment advice.